世界の組織診断（Tissue Diagnostics）市場動向と予測（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 18)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.2.1 Key Data Points From Primary Sources
1.5.3 Market Size Estimation Methodology
1.5.4 Market Forecast
1.5.5 Market Data Validation & Data Triangulation
1.6 Assumptions

2 Executive Summary (Page No. – 30)

3 Premium Insights (Page No. – 34)

4 Market Overview (Page No. – 41)
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Rising Incidence Of Cancer Is The Primary Driver For The Tissue Diagnostics Market
4.3.1.2 Rapidly Aging Population Will Increase The Disease Burden Of Non-Communicable Diseases
4.3.1.3 Increased Use Of Personalized Medicine For Cancer Will Drive The Demand For Tissue-Based Companion Diagnostic Tests
4.3.1.4 Growth in The Ivd Market Will Aid The Growth Of The Tissue Diagnostics Market
4.3.2 Restraints
4.3.2.1 Lack Of Budget To Restrict The Growth Of The Market
4.3.2.2 Stringent Regulatory Framework Acts As A Major Challenge For The Tissue Diagnostics Market
4.4 Market Share Analysis
4.5 Porter’s Analysis
4.5.1 Threat From New Entrants
4.5.2 Threat From Substitutes
4.5.3 Bargaining Power Of Buyers
4.5.4 Bargaining Power Of Suppliers
4.5.5 Competitive Rivalry Among Existing Players

5 Global Tissue Diagnostics Market, By Technology (Page No. – 55)
5.1 Introduction
5.2 Immunohistochemistry (IHC)
5.3 In Situ Hybridization (ISH)
5.4 Digital Pathology and Workflow Management
5.5 Special Staining

6 Global Tissue Diagnostics Market, By Disease (Page No. – 68)
6.1 Introduction
6.2 Breast Cancer
6.3 Gastric Cancer
6.4 Lymphoma
6.5 Prostate Cancer
6.6 Non-Small Cell Lung Carcinoma (NSCLC)
6.7 Other Diseases

7 Global Tissue Diagnotics Market, By Product (Page No. – 85)
7.1 Introduction
7.2 Instruments
7.3 Consumables

8 Global Tissue Diagnostics Market, By End User (Page No. – 93)
8.1 Introduction
8.2 Hospitals
8.3 Pharmaceutical Companies
8.4 Research Laboratories
8.5 Contract Research Organizations (CRO)
8.6 Other End-Users

9 Geographic Analysis (Page No. – 105)
9.1 Introduction
9.2 The Americas
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.2.4 Chile
9.2.5 Rest Of Americas (ROA)
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 Spain
9.3.5 U.K.
9.3.6 Rest Of Europe (ROE)
9.4 BRIC
9.4.1 Brazil
9.4.2 China
9.4.3 India
9.4.4 Russia
9.5 Japan
9.6 Rest Of The World (ROW)

10 Competitive Landscape (Page No. – 195)
10.1 Introduction
10.2 New Product Launches
10.3 Agreements, Collaborations, Expansions, Joint Ventures and Partnerships
10.4 Mergers and Acquisitions
10.5 Other Developments

11 Company Profiles (Business Overview, Products & Services, Key Strategy, & Recent Developments)* (Page No. – 204)
11.1 Abbott Laboratories, Inc.
11.2 Agilent Technologies
11.3 Biogenex Laboratories
11.4 Bio Sb.
11.5 Cell Signalling Technology, Inc.
11.6 Danaher Corporation.
11.7 Life Technologies
11.8 Roche
11.9 Sigma Aldrich
11.1 Thermo Fisher Scientific

*Details on Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case Of Unlisted Companies.

Appendix (Page No. – 251)